Cargando…

Therapy Targets SARS-CoV-2 Infection-Induced Cell Death

Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global health issue. The clinical presentation of COVID-19 is highly variable, ranging from asymptomatic and mild disease to severe. However, the mechanisms for the high mortality induced by SARS-CoV-2 infection are still not well...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Zhoujie, Shi, Jiayi, Li, Long, Wang, Jinling, Zhao, Yufen, Ma, Huabin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152132/
https://www.ncbi.nlm.nih.gov/pubmed/35655782
http://dx.doi.org/10.3389/fimmu.2022.870216
_version_ 1784717577543483392
author Zhu, Zhoujie
Shi, Jiayi
Li, Long
Wang, Jinling
Zhao, Yufen
Ma, Huabin
author_facet Zhu, Zhoujie
Shi, Jiayi
Li, Long
Wang, Jinling
Zhao, Yufen
Ma, Huabin
author_sort Zhu, Zhoujie
collection PubMed
description Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global health issue. The clinical presentation of COVID-19 is highly variable, ranging from asymptomatic and mild disease to severe. However, the mechanisms for the high mortality induced by SARS-CoV-2 infection are still not well understood. Recent studies have indicated that the cytokine storm might play an essential role in the disease progression in patients with COVID-19, which is characterized by the uncontrolled release of cytokines and chemokines leading to acute respiratory distress syndrome (ARDS), multi-organ failure, and even death. Cell death, especially, inflammatory cell death, might be the initiation of a cytokine storm caused by SARS-CoV-2 infection. This review summarizes the forms of cell death caused by SARS-CoV-2 in vivo or in vitro and elaborates on the dedication of apoptosis, necroptosis, NETosis, pyroptosis of syncytia, and even SARS-CoV-2 E proteins forming channel induced cell death, providing insights into targets on the cell death pathway for the treatment of COVID-19.
format Online
Article
Text
id pubmed-9152132
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91521322022-06-01 Therapy Targets SARS-CoV-2 Infection-Induced Cell Death Zhu, Zhoujie Shi, Jiayi Li, Long Wang, Jinling Zhao, Yufen Ma, Huabin Front Immunol Immunology Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global health issue. The clinical presentation of COVID-19 is highly variable, ranging from asymptomatic and mild disease to severe. However, the mechanisms for the high mortality induced by SARS-CoV-2 infection are still not well understood. Recent studies have indicated that the cytokine storm might play an essential role in the disease progression in patients with COVID-19, which is characterized by the uncontrolled release of cytokines and chemokines leading to acute respiratory distress syndrome (ARDS), multi-organ failure, and even death. Cell death, especially, inflammatory cell death, might be the initiation of a cytokine storm caused by SARS-CoV-2 infection. This review summarizes the forms of cell death caused by SARS-CoV-2 in vivo or in vitro and elaborates on the dedication of apoptosis, necroptosis, NETosis, pyroptosis of syncytia, and even SARS-CoV-2 E proteins forming channel induced cell death, providing insights into targets on the cell death pathway for the treatment of COVID-19. Frontiers Media S.A. 2022-05-17 /pmc/articles/PMC9152132/ /pubmed/35655782 http://dx.doi.org/10.3389/fimmu.2022.870216 Text en Copyright © 2022 Zhu, Shi, Li, Wang, Zhao and Ma https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Zhu, Zhoujie
Shi, Jiayi
Li, Long
Wang, Jinling
Zhao, Yufen
Ma, Huabin
Therapy Targets SARS-CoV-2 Infection-Induced Cell Death
title Therapy Targets SARS-CoV-2 Infection-Induced Cell Death
title_full Therapy Targets SARS-CoV-2 Infection-Induced Cell Death
title_fullStr Therapy Targets SARS-CoV-2 Infection-Induced Cell Death
title_full_unstemmed Therapy Targets SARS-CoV-2 Infection-Induced Cell Death
title_short Therapy Targets SARS-CoV-2 Infection-Induced Cell Death
title_sort therapy targets sars-cov-2 infection-induced cell death
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152132/
https://www.ncbi.nlm.nih.gov/pubmed/35655782
http://dx.doi.org/10.3389/fimmu.2022.870216
work_keys_str_mv AT zhuzhoujie therapytargetssarscov2infectioninducedcelldeath
AT shijiayi therapytargetssarscov2infectioninducedcelldeath
AT lilong therapytargetssarscov2infectioninducedcelldeath
AT wangjinling therapytargetssarscov2infectioninducedcelldeath
AT zhaoyufen therapytargetssarscov2infectioninducedcelldeath
AT mahuabin therapytargetssarscov2infectioninducedcelldeath